Mexico City, Mexico

Gustavo A Garcia

This inventor holds 1 USPTO granted patent. Top assignee: Fermic S.a. De C.v.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gustavo A Garcia. Retrieved from https://idiyas.com/inventor/gustavo-a-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Gustavo A Garcia in Pharmaceutical Chemistry

Introduction

Gustavo A Garcia is a notable inventor based in Mexico City, MX. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of simvastatin, a widely used cholesterol-lowering medication. His innovative methods have enhanced the efficiency and purity of simvastatin production.

Latest Patents

Gustavo A Garcia holds a patent for a method titled "Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin." This patent describes a process that produces simvastatin from lovastatin in high yield and pharmaceutical purity. The method involves forming an amide of lovastatin and protecting the free hydroxyl groups with hexamethyldisilazane (HMDS). The alpha-carbon of the 2-methylbutyrate secondary chain of the protected lovastatin amide is then methylated to form a protected simvastatin amide. The process allows for the removal of protecting groups through water quenching, simplifying the overall reaction. The lactonization reaction can be conducted using low boiling point solvents and inorganic acids as catalysts, further enhancing the efficiency of simvastatin production.

Career Highlights

Gustavo A Garcia is associated with Fermic S.A. de C.V., where he has been instrumental in advancing pharmaceutical manufacturing techniques. His work has not only contributed to the field of drug synthesis but has also positioned his company as a leader in pharmaceutical innovation.

Collaborations

Gustavo has collaborated with notable colleagues such as Edvige Galeazzi and Fernando Lara. Their combined expertise has fostered a productive environment for research and development in pharmaceutical chemistry.

Conclusion

Gustavo A Garcia's innovative methods in the synthesis of simvastatin exemplify the impact of inventive thinking in the pharmaceutical industry. His contributions continue to influence the field and improve drug production processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…